Paper Details

  1. Home
  2. Paper Details

A Review of Suvorexant, Doxepin, Ramelteon, and Tasimelteon for the Treatment of Insomnia in Geriatric Patients.

Author: EdmondsChelsey, SwanoskiMichael

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.

Overview

Geriatric patients often experience insomnia. This paper explores and outlines the available safety and efficacy data associated with suvorexant, doxepin, ramelteon, and tasimelteon and reviews their potential place in therapy in treating insomnia in the geriatric population.
Paper Details　
Original Abstract of the Article :
Geriatric patients often experience insomnia because of physiological and neurological changes that occur during the aging process. Use of benzodiazepines, nonbenzodiazepine hypnotics, and diphenhydramine for the treatment of insomnia pose an increased risk of cognitive impairment, falls, and fractu...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.4140/TCP.n.2017.156

データ提供：米国国立医学図書館（NLM）

Navigating Insomnia in the Elderly: A Guide Through the Desert of Sleeplessness

This review delves into the challenges of insomnia in the geriatric population, a prevalent condition that can significantly impact quality of life. The study examines the safety and efficacy of four FDA-approved medications for insomnia in older adults, including suvorexant, doxepin, ramelteon, and tasimelteon, providing valuable insights into their potential benefits and risks.

Seeking Oasis in the Desert of Insomnia

This review offers a comprehensive guide for navigating the desert of insomnia in the elderly population. The study provides valuable information on the safety and efficacy of four FDA-approved medications, enabling healthcare professionals to make informed decisions about the most appropriate treatment options for their patients.

Understanding the Impact of Sleeplessness in Older Adults

This research highlights the importance of addressing insomnia in the elderly population. The study underscores the need for effective treatments that are both safe and effective in this vulnerable group, emphasizing the crucial role of comprehensive sleep care in promoting overall well-being.

Dr. Camel's Conclusion

The desert of insomnia can be particularly challenging for older adults, often leading to decreased quality of life and increased health risks. This review provides a helpful guide through the shifting sands of treatment options, offering valuable insights into the potential benefits and risks of four FDA-approved medications for insomnia in this vulnerable population. By understanding the intricacies of sleep disturbances in the elderly, we can better navigate this challenging terrain and ensure the best possible outcomes for our patients.

Date :
  1. Date Completed 2017-06-26
  2. Date Revised 2017-06-26
Further Info :

Pubmed ID

28270270

DOI: Digital Object Identifier

10.4140/TCP.n.2017.156

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.